N-4
Active substance: CHELIDONIUM MAJUS, BRYONIA ALBA ROOT, STRYCHNOS NUX-VOMICA SEED, LYCOPODIUM CLAVATUM WHOLE, MAMMAL LIVER, SODIUM SULFATE, MILK THISTLE
SOLUTION · CHELIDONIUM MAJUS 4 [hp_X]/mL, BRYONIA ALBA ROOT 4 [hp_X]/mL, STRYCHNOS NUX-VOMICA SEED 6 [hp_X]/mL, LYCOPODIUM CLAVATUM WHOLE 4 [hp_X]/mL, MAMMAL LIVER 200 [hp_X]/mL, SODIUM SULFATE 4 [hp_X]/mL, MILK THISTLE 4 [hp_X]/mL
United StatesActive
Marketing holder: DNA Labs, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CHELIDONIUM MAJUS · 4 [hp_X]/mL
- BRYONIA ALBA ROOT · 4 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED · 6 [hp_X]/mL
- LYCOPODIUM CLAVATUM WHOLE · 4 [hp_X]/mL
- MAMMAL LIVER · 200 [hp_X]/mL
- SODIUM SULFATE · 4 [hp_X]/mL
- MILK THISTLE · 4 [hp_X]/mL
Registration
- Registration number
- 58264-0202
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- SUBLINGUAL
Sources
- product · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 58264-0202 · Verified 2026-10-09 · open in source